HOME >> BIOLOGY >> NEWS
Conservationist and actor Harrison Ford honored by Congressional Foundation

Washington D.C. (Sept. 19, 2006) -- Actor and Conservation International (CI) board member Harrison Ford was honored at the inaugural gala for the International Conservation Caucus Foundation (ICCF) dedicated to raising awareness in Congress about international conservation issues. An active member of CI's board of directors for more than 15 years, Ford continues to be an integral part in shaping Conservation International's mission to conserve biodiversity around the world. Ford was recognized Tuesday night with the "ICCF Good Steward Award" for his lifetime of passion toward environmental issues.

"We can unite the world to take individual responsibility by establishing a global conservation ethic that every person rich, poor, indigenous can embrace," Ford said in his acceptance remarks. "We need every person on the planet, all 6.5 billion inhabitants, to understand that they must do their part and take individual responsibility for conserving, protecting and restoring nature."

Ford has also been deeply involved with other conservation groups with work such as:

  • Narrating PSAs for Conservation International, Earthshare, and Environmental Media Association
  • Receiving a Lindbergh award for his work patrolling the Hudson River watershed by helicopter as Riverkeepers' first "airborne watchdog"
  • Donating half of his Jackson, Wyoming estate to the Jackson Hole Land Trust as a conservation easement

The ICCF also honored Yves Chouinard, Founder of Patagonia, and Office of Management and Budget Director Rob Portman. As the original author of the Tropical Forests Conservation Act (TFCA), Portman helped create the framework for many developing nations to engage in "debt for nature" swaps with the U.S. Government, which offer them the opportunity to relieve some official debt owed the U.S. while at the same time generating funds to conserve their country's natural heritage.


'"/>

Contact: Marshall Maher
mmaher@conservation.org
202-912-1411
Conservation International
20-Sep-2006


Page: 1

Related biology news :

1. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
2. OHSU turns mouse into factory for human liver cells
3. Genetic factors strongly shape how peers are chosen
4. Injection drug use the most important risk factor for HIV and HCV infections among Quebec prisoners
5. After a decades-long search, scientists identify new genetic risk factors for multiple sclerosis
6. New model for autism suggests women carry the disorder and explains age as a risk factor
7. Obesity found to be a risk factor for multiple myeloma
8. Journal of Alzheimers Disease achieves significant impact factor
9. Tomorrows green nanofactories
10. Study identifies a common genetic risk factor for colorectal and prostate cancer
11. Male or female factor infertility -- men suffer just the same

Post Your Comments:
(Date:3/20/2015)... and Markets ( http://www.researchandmarkets.com/research/vkzvcs/iris_biometrics ) has announced the ... Report" report to their offering. This report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... . Annual estimates and forecasts are provided ...
(Date:3/17/2015)... , March 17, 2015  MecklerMedia Corporation ... largest exhibition for service robots ever held in ... takes place on May 11-13, 2015 at the ... exhibitors for the event include: Acorn Product Development; ... EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic Corporation; Neya ...
(Date:3/12/2015)... 2015 WHEN:Tuesday, March 17, 2015 at 11:00 ... . SPEAKERS: , Frost & Sullivan Measurement & ... Biometric companies must plan for ... different markets and industries. This is especially true ... Join Frost & Sullivan,s upcoming ...
Breaking Biology News(10 mins):Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 2Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 3Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 4Iris Biometrics - Global Strategic Business Report 2015: System & Network Access Control - A Robust Market Opportunity in the Offing 5MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3
(Date:3/30/2015)... PMG Research, Benchmark Research, and Miami ... of VaxCorps, a network of highly experienced, geographically ... of vaccine trials in healthy adult, elderly, and ... conducted over 500 phase I-III vaccine clinical trials, ... as well as a vast array of other ...
(Date:3/30/2015)... 30, 2015  NuGene International, Inc. ("NuGene") (OTCQB: ... BioPharma, Inc. has added another internationally recognized researcher ... is an internationally recognized researcher in bio-inspired materials ... at Peking University, China , ... University of North Carolina, Chapel Hill. Following a ...
(Date:3/30/2015)... -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI ), a ... of innovative therapeutics addressing cancer and other unmet medical ... on China , announced today that ... the Company,s application to conduct a Phase 2 global ... for its proprietary drug candidate ENMD-2076.  ...
(Date:3/30/2015)... Md. , March 30, 2015  Spherix ... company committed to the fostering and monetization of ... v. VTech,  Case No. 3:13-cv-03494-M and  Spherix v. ... United States District Court for the Northern District ... update regarding Spherix v. Verizon, Case ...
Breaking Biology Technology:PMG Research announces formation of VaxCorps with two industry-leading vaccine site networks 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 2UCI Professor Zhibin Guan Joins NuGene Advisory Board 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 3
Cached News: